NKLA: Nikola Update
Well, that did not take long. The day after we discussed Nikola, the new kid on the EV block, Hindenburg Research put out a very negative research report on the…
Well, that did not take long. The day after we discussed Nikola, the new kid on the EV block, Hindenburg Research put out a very negative research report on the…
There has never been any doubt in our minds that competitors in the electric car spaces would come out of the woodwork. Every incumbent car company will be introducing electric…
Lululemon Athletica Inc. is a Canadian company that focuses on the retail athletic apparel and accessories category for both men & women. We know several women who buy and wear…
In our view, bonds & the US Dollar are the keys to the equity market's future performance. Both subjects are worth talking about, but today, we will focus on bonds.…
Carter Braxton Worth took a closer look at the broad market represented by the S&P500 and the NASDAQ 100. Every one of us has this uneasy feeling when stocks rise…
Back in March, we had high hopes for Pfizer. We thought they might lead the charge in finding a cure, treatment, or vaccine against the Covid-19. But even if they…
We have talked about the Fed's misguided monetary policy and how they have inflated asset prices in a vain attempt to stall the recession caused by the government's shutdown of…
David, one of our good friends and subscriber to theOptionsEdge.Com, informed us that he participated in the bearish Mondelez trade suggestion. The share price sneaked up slightly higher than we…
The riots that have spread across major cities around the country have people concerned about their safety. One of the average person's responses to the violence is the purchase of…
Biogen is a ridiculously successful company. They have developed therapies to treat or cure several debilitating diseases. The odd phenomenon about the current investment environment is that investors would rather…